Assisted Reproductive Technology (ART) Market Overall Growth, Future Scope, Industry Trends And Forecast 2025| Grand View Research, Inc
“The global assisted reproductive technology market size was estimated to be around USD 21 billion in 2017 and is anticipated to grow at a CAGR of 10% over the forecast period.�
The global assisted reproductive technology (ART) market is expected to reach USD 45 billion by 2025, according to a new report by Grand View Research, Inc. Childbearing postponement is one of the high impact rendering drivers of the infertility treatment market. The reproductive behavior and pattern of some of the nations such as few European nations have shifted from early to late childbearing pattern. Increasing marital age, rising tobacco and alcohol consumption, increasing obesity rate are some of the other factors contributing to the market growth. Furthermore, increasing incidence rate of conditions such as poly-cystic ovarian syndrome (PCOS), tubal factors and endometriosis are other drivers of the market. According to the Society for Assisted Reproductive Technology, 2012 was the year with highest percentage of babies born through IVF treatment. The treatment has become more successful and has gained more acceptance, which is further expected to increase the market size in the coming years.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/assisted-reproductive-technologymarket
Follow Us:
Further Key Findings from the Report Suggest: Fresh non-donor was the largest ART market procedure segment in 2014. The fact that fresh eggs and sperms increase the number of successful pregnancies is expected to drive segment growth over the forecast period.
According to a recent study published in the New England Journal of Medicine.by the researchers from Vietnam and China, frozen embryos are not more effective in comparison to the fresh embryos for all women, specifically those suffering from PCOS.
Frozen non-donor is identified as the most lucrative procedure segment of the assisted reproductive technology industry. A new study claims that the fertility treatment with frozen embryos may have more probability of success than those performed with fresh embryos.
IVF with ICSI dominated the technology type market segment owing to increase in the chances of successful fertilization, and exceptional technique for treating male infertility. As per the study published in fertility journal Human Reproduction Update 2017, North America, Europe, New Zealand and Australia, men’s sperm counts declined by 50-60% over the period between 1973 and 2011. Changing lifestyle and environmental factors are some of the factors responsible for the decline of sperm counts.
Frozen embryo replacement (FER) is anticipated to grow at a rapid rate over the forecast period owing to the fact that in the clinics fresh embryos are used first and only good quality and spare embryos are transferred at a later stage. The trend is to transfer single embryos rather than risking by transferring two or more embryos. This is expected to increase the FER segment market in the coming years.
Europe dominated the market and is anticipated to maintain its dominance during the forecast period The Asia Pacific region is likely to witness significant growth over the next decade due to improving healthcare infrastructure, increasing awareness and adoption of IVF procedures.
Technological advancements is expected to drive the market in the coming years. In 2016, INVO Bioscience, Inc. announced the FDA approval of first intravaginal culture system, INVOcell, wherein women’s vagina is used as a natural incubator and the clinical trials have produced pregnancy similar to traditional IVF treatments
Some of the key players are California Cryobank, Bloom IVF Centre, Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Ferring Pharmaceuticals, Boston Science Corporation and Hamilton Throne Ltd.
Grand View Research has segmented the global assisted reproductive technology market based on procedure, type, end use and region: Procedure Outlook (Revenue, USD Million, 2014 - 2025) Fresh Donor
Fresh Non-Donor
Frozen Donor
Frozen Non-donor
Embryo/Egg Banking
Type Outlook(Revenue, USD Million, 2014 - 2025) In-Vitro Fertilization (IVF)
Follow Us:
o
IVF with Intracytoplasmic Sperm Injection (ICSI)
o
IVF without Intracytoplasmic Sperm Injection (ICSI)
AI-IUI (Artificial Insemination - Intrauterine Insemination
Frozen Embryo Replacement (FER)
Others
End Use Outlook (Revenue, USD Million, 2014 - 2025) Hospitals
Fertility Clinics
Regional Outlook (Revenue, USD Million, 2014 - 2025) North America
o
U.S.
o
Canada
Europe o
UK
o
France
o
Germany
Asia Pacific o
China
o
Japan
o
India
Latin America o
Brazil
o
Mexico
Middle East & Africa o
South Africa
Browse Related Category Reports @ www.grandviewresearch.com/industry/clinical-diagnostics
Follow Us:
Table of Content of Assisted Reproductive Technology (ART) Market Chapter 1 Executive Summary 1.1 Market Snapshot Chapter 2 Research Methodology 2.1 Information Procurement 2.2 Data Analysis Chapter 3 Market Variables, Trends, & Scope 3.1 Market Segmentation & Scope 3.1.1 Market driver analysis 3.1.1.1 Constant rise in infertility rate 3.1.1.2 Growing awareness and social acceptance of assisted reproductive technologies 3.1.1.3 Increasing number of single women and same-sex couples 3.1.2 Market restraints analysis 3.1.2.1 Changing government regulations 3.2 Penetration & Growth Prospect Mapping 3.3 Assisted Reproductive Technology - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological) 3.4 Assisted Reproductive Technology - Industry Analysis - Porter’s Chapter 4 Assisted Reproductive Technology (ART) Market: Procedure Estimates & Trend Analysis 4.1 Assisted Reproductive Technology (ART): Procedure Analysis 4.2 Fresh Donor 4.2.1 Fresh donor market, 2014 - 2025 (USD Million) 4.3 Fresh Nondonor 4.3.1 Fresh nondonor market, 2014 - 2025 (USD Million) 4.4 Frozen Donor 4.4.1 Frozen donor market, 2014 - 2025 (USD Million) 4.5 Frozen Nondonor 4.5.1 Frozen nondonor market, 2014 - 2025 (USD Million) 4.6 Embryo/Egg Banking 4.6.1 Embryo/egg banking market, 2014 - 2025 (USD Million) Chapter 5 Assisted Reproductive Technology (ART) Market: Type Estimates & Trend Analysis 5.1 Assisted Reproductive Technology (ART): Type Analysis
Follow Us:
5.2 IVF 5.2.1 IVF market, 2014 - 2025 (USD Million) 5.2.1.1 IVF with ICSI 5.2.1.2 IVF without ICSI 5.3 AI-IUI 5.3.1 AI-IUI market, 2014 - 2025 (USD Million) 5.4 FER 5.4.1 FER market, 2014 - 2025 (USD Million) 5.5 Others 5.5.1 Others market, 2014 - 2025 (USD Million) Chapter 6 Assisted Reproductive Technology (ART) Market: End-use Estimates & Trend Analysis 6.1 Assisted Reproductive Technology (ART): End-use Analysis 6.2 Hospital 6.2.1 Hospital market, 2014 - 2025 (USD Million) 6.3 Fertility Clinics 6.3.1 Fertility clinics market, 2014 - 2025 (USD Million) Chapter 7 Assisted Reproductive Technology (ART) Market: Regional Estimates & Trend Analysis 7.1 Assisted Reproductive Technology (ART) Market: Regional Movement analysis 7.2 North America 7.2.1 North America Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S. Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.2.3 Canada 7.2.3.1 Canada Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.3 Europe 7.3.1 Europe Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.3.2 UK 7.3.2.1 UK Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.3.3 Germany 7.3.3.1 Germany Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.3.4 France 7.3.4.1 France Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
Follow Us:
7.4 Asia Pacific 7.4.1 Asia Pacific Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.4.2 Japan 7.4.2.1 Japan Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.4.3 China 7.4.3.1 China Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.4.4 India 7.4.4.1 India Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.5 Latin America 7.5.1 Latin America Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.5.2 Brazil 7.5.2.1 Brazil Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.5.3 Mexico 7.5.3.1 Mexico Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.6 Middle East and Africa (MEA) 7.6.1 Middle East and Africa Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) 7.6.2 South Africa 7.6.2.1 South Africa Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million) Chapter 8 Competitive Landscape 8.1 Strategy Framework 8.2 Company Profiles 8.2.1 Cosmos Biomedical 8.2.1.1 Company Overview 8.2.1.2. Financial Performance 8.2.1.3 Product Benchmarking 8.2.1.4 Strategic Initiatives 8.2.2 Microm UK Ltd. 8.2.2.1 Company Overview 8.2.2.2. Financial Performance 8.2.2.3 Product Benchmarking 8.2.2.4 Strategic Initiatives 8.2.3 Origio
Follow Us:
8.2.3.1 Company Overview 8.2.3.2. Financial Performance 8.2.3.3 Product Benchmarking 8.2.3.4 Strategic Initiatives 8.2.4 IrvineScientific 8.2.4.1 Company Overview 8.2.4.2. Financial Performance 8.2.4.3 Product Benchmarking 8.2.4.4 Strategic Initiatives 8.2.5 Cryolab Ltd. 8.2.5.1 Company Overview 8.2.5.2. Financial Performance 8.2.5.3 Product Benchmarking 8.2.5.4 Strategic Initiatives 8.2.6 Parallabs 8.2.6.1 Company Overview 8.2.6.2. Financial Performance 8.2.6.3 Product Benchmarking 8.2.6.4 Strategic Initiatives 8.2.7 European Sperm Bank 8.2.7.1 Company Overview 8.2.7.2. Financial Performance 8.2.7.3 Product Benchmarking 8.2.7.4 Strategic Initiatives 8.2.8 Bloom IVF Centre 8.2.8.1 Company Overview 8.2.8.2. Financial Performance 8.2.8.3 Product Benchmarking 8.2.8.4 Strategic Initiatives 8.2.9 Ovascience 8.2.9.1 Company Overview 8.2.9.2. Financial Performance
Follow Us:
8.2.9.3 Product Benchmarking 8.2.9.4 Strategic Initiatives 8.2.10 Ferring Pharmaceuticals 8.2.10.1 Company Overview 8.2.10.2. Financial Performance 8.2.10.3 Product Benchmarking 8.2.10.4 Strategic Initiatives
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us:
Follow Us: